Top
Begin typing your search...

Aurobindo Pharma Q4 net up at Rs 801.18 cr

Aurobindo Pharma Q4 net up at Rs 801.18 cr
X

Aurobindo Pharma Q4 net up at Rs 801.18 cr

  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Print

New Delhi Drug firm Aurobindo Pharma on Monday reported a consolidated net profit of Rs 801.18 crore for the fourth quarter ended March 2021. The company had posted a net profit of Rs 863.16 crore for the corresponding period of the previous fiscal, Aurobindo Pharma said in a regulatory filing. Its consolidated revenue from operations stood at Rs 6,001.50 crore for the quarter under consideration. It was Rs 6,158.43 crore a year ago, it added. "Net profit after JV share, minority interest is not comparable due to Natrol divestment," Aurobindo Pharma said. For the fiscal ended March this year, the company posted a net profit of Rs 5,333.83 crore. It was Rs 2,843.67 crore in the preceding fiscal year, the filing said. The company's revenue from operations stood at Rs 24,774.63 crore for 2020-21. It was Rs 23,098.50 crore in the previous fiscal, it added. "We are pleased to have ended the fiscal year with steady growth across our key businesses in a dynamic environment affected by the pandemic," Aurobindo Pharma MD N Govindarajan said.

Bizz Buzz
Next Story
Share it